These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11011241)

  • 1. [Pharmacoepidemiology of diabetes: assessment of good use of oral antidiabetic drugs].
    Vauzelle-Kervroëdan F; Javoy F; Forhan A; Fender P; Eschwège E
    Diabetes Metab; 2000 Sep; 26 Suppl 6():63-8. PubMed ID: 11011241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacoepidemiology of diabetes: contribution of a survey of health insurance cases].
    Vauzellé-Kervroedan F; Forhan A; Javoy F; Fender P; Eschwege E
    Diabetes Metab; 1999 Jun; 25(2):163-71. PubMed ID: 10443328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Trends in prescribing oral antidiabetic drugs. An analysis of the Berlin diabetes register covering 28 years].
    Ratzmann KP; Thoelk H
    Med Klin (Munich); 1992 Jan; 87(1):8-11. PubMed ID: 1545772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and costs of diabetes treated with insulin in France.
    Detournay B; Raccah D; Cadilhac M; Eschwège E
    Diabetes Metab; 2005 Jun; 31(3 Pt 2):3-18. PubMed ID: 16142041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How many and who are receiving medication for diabetes mellitus?].
    Strøm H; Engeland A; Eriksen E; Sakshaug S; Rønning M
    Tidsskr Nor Laegeforen; 2006 Mar; 126(6):768-70. PubMed ID: 16541171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
    Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
    G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using a pharmaco-epidemiological approach to estimate diabetes type 2 prevalence in Portugal.
    Duarte-Ramos F; Cabrita J
    Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):269-74. PubMed ID: 16294365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regional prevalence of diabetes treated with oral hypoglycemic agents].
    Vauzelle-Kervroedan F; Forhan A; Papoz L
    Diabete Metab; 1993; 19(3):291-5. PubMed ID: 8405619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and pharmacotherapy of diabetes mellitus in primary care].
    Lehnert H; Wittchen HU; Pittrow D; Bramlage P; Kirch W; Böhler S; Höfler M; Ritz E
    Dtsch Med Wochenschr; 2005 Feb; 130(7):323-8. PubMed ID: 15712019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in outpatient prescription drug costs in diabetic patients in Germany, 1994-2004.
    Rathmann W; Haastert B; Icks A; Giani G
    Diabetes Care; 2007 Apr; 30(4):848-53. PubMed ID: 17392545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Aquilante CL; Zhang W; McCollum M
    Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB; Kranjcević K; Reiner Z; Blazeković SM; Spehar SS
    Croat Med J; 2005 Dec; 46(6):984-9. PubMed ID: 16342354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in antihypertensive drug use among orally treated diabetic patients, in France between 1981 and 1992. Impact of guidelines and new drugs.
    Maison P; Planchat-Fely P; Vauzelle-Kervroëdan F; Sermet C; Eschwège E
    Diabetes Metab; 2001 Dec; 27(6):661-5. PubMed ID: 11852374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refill adherence to oral antihyperglycaemic drugs in Sweden.
    Haupt D; Weitoft GR; Nilsson JL
    Acta Diabetol; 2009 Sep; 46(3):203-8. PubMed ID: 19023514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug prescription in men and women with type-2 diabetes in Stockholm in 1995 and 2001: change over time.
    Wändell PE; Gåfvels C
    Eur J Clin Pharmacol; 2002 Nov; 58(8):547-53. PubMed ID: 12451433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of an antidiabetic treatment with sulfonylurea drugs on long-term survival after acute myocardial infarction in patients with type 2 diabetes. The LAngendreer Myocardial infarction and Blood glucose in Diabetic patients Assessment (LAMBDA).
    Meier JJ; Deifuss S; Klamann A; Schmiegel W; Nauck MA;
    Exp Clin Endocrinol Diabetes; 2003 Sep; 111(6):344-50. PubMed ID: 14520601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001.
    Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A
    Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Fisman EZ; Tenenbaum A; Motro M; Adler Y
    Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.